Claudio Willbert Ramírez Atencio

Dr. Claudio Willbert Ramírez Atencio

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
KSKelly Geraldine Yparraguirre Salcedo
Kelly Geraldine Yparraguirre Salcedo
APAnthony Brayan Rivera Prado
Anthony Brayan Rivera Prado
LLLuis Lloja Lozano
Luis Lloja Lozano
VQVicente Chambilla Quispe
Vicente Chambilla Quispe
CAClaudio Willbert Ramírez Atencio
Claudio Willbert Ramírez Atencio
The success of an athlete is influenced by various factors, including nutritional status, physical condition, training level, recovery, psychological factors, and genetics. Studies on athletes often take a preventive approach to evaluate muscle fatigue caused by intense physical exercise, which can impair performance, particularly in soccer players. This study aims to determine the serum levels of biochemical markers of muscle damage in adolescents from sports centers in the city of Tacna. A sample of 326 adolescents who met the inclusion and exclusion criteria was analyzed for muscle damage markers, including CRP, LDH, CK-total, and CK-MB, to assess potential skeletal muscle injury. The results were as follows: for the LDH test, 2.5% had low-level values, 91.4% had values within the normal range, and 6.1% had high values; for the CK-total test, 74.8% were within normal limits, and 25.2% had elevated values; for the CK-MB test, 99.1% had normal values, and 0.9% had elevated values; and for the CRP test, 95.7% were negative, and 4.3% were positive. According to the CK-MB/CK relative index, 7.1% of adolescents were suspected of having muscle damage. This study concludes that there are alterations in the biochemical markers of muscle damage in adolescents from the sports centers in Tacna.

27 January 2026 in Applied Microbiology
Verified
Journal Article
Open access
PDF file
AMAngelica Beatriz Condori Mamani
Angelica Beatriz Condori Mamani
APAnthony Brayan Rivera Prado
Anthony Brayan Rivera Prado
KSKelly Geraldine Yparraguirre Salcedo
Kelly Geraldine Yparraguirre Salcedo
LLLuis Lloja Lozano
Luis Lloja Lozano
VQVicente Chambilla Quispe
Vicente Chambilla Quispe
CAClaudio Willbert Ramírez Atencio
Claudio Willbert Ramírez Atencio
Giardiasis, caused by the protozoan parasite Giardia lamblia, remains a prevalent intestinal infection worldwide and a growing concern due to increasing resistance to nitroimidazole drugs. This study proposes an alternative therapeutic strategy by targeting fructose-1,6-bisphosphate aldolase (FBPA), a key glycolytic enzyme of the parasite, through structure-based virtual screening. A curated library of microbiome-derived metabolites was computationally evaluated and compared with clinically used antigiardial drugs. Several indole-based compounds exhibited favorable binding affinities and stable interactions within the catalytic pocket of FBPA. These findings suggest that microbiome metabolites could serve as promising scaffolds for the rational design of new antiparasitic agents. Overall, the study highlights the potential of integrating metabolic and computational approaches to identify next-generation therapeutics against giardiasis.

15 March 2026 in Diseases
Verified
Journal Article
Open access
PDF file
APAnthony Brayan Rivera Prado
Anthony Brayan Rivera Prado
LLLuis Lloja Lozano
Luis Lloja Lozano
DDDaysi Zulema Diaz-Obregón
Daysi Zulema Diaz-Obregón
VZVíctor Hugo Carbajal Zegarra
Víctor Hugo Carbajal Zegarra
JDJoel de León Delgado
Joel de León Delgado
CAClaudio Willbert Ramírez Atencio
Claudio Willbert Ramírez Atencio
Background: Chronic liver fibrosis is a progressive pathological condition characterized by excessive extracellular matrix deposition and architectural remodeling, which may ultimately lead to cirrhosis and liver failure. Although mesenchymal stem cells (MSCs) exhibit antifibrotic and immunomodulatory properties, their therapeutic effects in established chronic liver fibrosis remain incompletely defined. This study aimed to evaluate the biochemical, hematological, and histopathological effects of MSC therapy in a chronic thioacetamide-induced liver fibrosis model. Methods: A controlled preclinical experimental study was conducted using rats with liver fibrosis induced by intraperitoneal thioacetamide administration for 24 weeks. Animals were allocated into three groups: control, untreated fibrosis, and fibrosis treated with MSCs derived from human umbilical cord tissue after fibrosis establishment. Serum biochemical markers, hematological parameters, and liver histopathology were assessed. Fibrosis severity was evaluated using hematoxylin–eosin and Masson’s trichrome staining and graded according to the METAVIR scoring system. Results: Thioacetamide exposure induced chronic liver injury characterized by marked elevations in serum transaminases, reduced albumin and total protein levels, hematological alterations, and early-to-intermediate fibrosis stages (METAVIR F1–F2). MSC-treated animals exhibited approximately 40–45% reductions in transaminase levels, partial recovery of hepatic synthetic function, and attenuation of hematological alterations. Histopathological analysis demonstrated a reduction in fibrotic burden and limitation of fibrogenic progression within METAVIR F1–F2 stages. Conclusions: MSC therapy partially mitigates biochemical, hematological, and histopathological alterations associated with chronic thioacetamide-induced liver fibrosis, supporting its potential as a modulatory strategy to attenuate fibrogenic progression and stabilize liver function rather than as a curative intervention.

11 April 2026 in Diseases
Verified
Journal Article
Open access
PDF file
LQLesly Adelis Valdivia Quispe
Lesly Adelis Valdivia Quispe
LLLucio Velasco Lopez
Lucio Velasco Lopez
DDDAYSI ZULEMA DIAZ-OBREGON
DAYSI ZULEMA DIAZ-OBREGON
Alexis Murillo CarrascoAlexis Murillo Carrasco
Alexis Murillo Carrasco
JDJoel de León Delgado
Joel de León Delgado
CAClaudio Willbert Ramírez Atencio
Claudio Willbert Ramírez Atencio
Background/Objectives: Chemically induced hepatotoxicity is widely used in experimental research to model liver disease pathophysiology and to support preclinical studies. Thioacetamide (TAA) is a well-established hepatotoxic agent in conventional laboratory rodents; however, its effects in synanthropic rats—characterized by genetic heterogeneity and chronic environmental exposure—remain poorly defined. This study aimed to establish and characterize a preclinical model of TAA-induced hepatotoxicity in synanthropic rats and to assess its relevance for experimental liver disease research. Methods: Female synanthropic rats representing four phenotypic variants (albino, mottled, black, and brown; total n = 132) were housed under controlled conditions and assigned to control or TAA-treated groups. TAA was administered intraperitoneally at doses ranging from 200 to 300 mg/kg. Clinical parameters, including body weight and vital signs, were periodically monitored. Hematological profiles and serum biochemical markers of liver function were analyzed. Hepatic injury was evaluated by histopathological examination using hematoxylin–eosin staining. Statistical analyses were performed using R software, with p ≤ 0.05 considered statistically significant. Results: TAA-treated rats developed consistent clinical manifestations of hepatotoxicity, including progressive weight loss and reduced activity. Biochemical analyses revealed significant increases in serum transaminases, gamma-glutamyl transferase, and alkaline phosphatase, accompanied by alterations in hematological parameters. Histological evaluation demonstrated dose-dependent liver injury characterized by centrilobular necrosis, inflammatory infiltration, hepatocellular degeneration, and architectural disruption across all synanthropic rat variants. Conclusions: Synanthropic rats exhibit reproducible biochemical, hematological, and histopathological features of TAA-induced liver injury comparable to those reported in conventional laboratory strains. This model represents a robust preclinical approach for studying chemically induced hepatotoxicity and may provide enhanced translational relevance due to its genetic and environmental heterogeneity.

1 January 2024 in UCL Open Environment
Verified
Journal Article
Open access
DFDiego Fano-Sizgorich
Diego Fano-Sizgorich
MGMatthew O. Gribble
Matthew O. Gribble
CVCinthya Vásquez-Velásquez
Cinthya Vásquez-Velásquez
CAClaudio Willbert Ramírez Atencio
Claudio Willbert Ramírez Atencio
JAJulio Aguilar
Julio Aguilar
Gustavo F. GonzalesGustavo F. Gonzales
Gustavo F. Gonzales
Arsenic exposure during pregnancy might affect foetal development. Arsenic metabolism may modulate the potential damage to the fetus. Tacna has the highest arsenic exposure levels in Peru. However, this region also has the highest birth weight in Peru. It is not known if arsenic exposure is affecting maternal–perinatal health in Tacna. This study aimed to evaluate the association between urinary arsenic metabolism and birth outcomes, specifically birth weight and gestational age at birth in Tacna, Peru. A prospective cohort study was conducted, involving 158 pregnant women in Tacna, Peru, during January–November 2019. Participants were enrolled in their second trimester and followed-up until birth. Urine samples were collected in the second and third trimesters. Urine samples were analysed for total arsenic concentration and its species. Generalised estimating equations analysis was used to evaluate the association of interest. Inter-differences in arsenic toxicokinetics, calculated with principal component analysis was included as an interaction term. Analysis was stratified by pregnancy trimester. The median total urinary arsenic concentration was 33.34 μg/L. Inorganic arsenic and dimethylarsinic acid were higher in the second trimester. Dimethylarsinic acid was the predominant component (84.78% of total urinary arsenic). No significant association was found between urinary arsenic exposure and birth weight or gestational age at birth. The association was not affected by arsenic metabolism. Stratified analyses by pregnancy trimester also showed no significant associations. Urinary arsenic was not associated with birth weight, and this null relationship remained unaffected by arsenic toxicokinetic differences reflected in urine.

4 November 2024 in UCL Open Environment Preprint
Verified
Preprint
Open access
DFDiego Fano-Sizgorich
Diego Fano-Sizgorich
MGMatthew O. Gribble
Matthew O. Gribble
CVCinthya Vásquez-Velásquez
Cinthya Vásquez-Velásquez
CAClaudio Willbert Ramírez Atencio
Claudio Willbert Ramírez Atencio
JAJulio Aguilar
Julio Aguilar
Gustavo F. GonzalesGustavo F. Gonzales
Gustavo F. Gonzales